News search

E.g., 22/11/2024
E.g., 22/11/2024
Dr. Cristóbal Belda se convirtió en el nuevo Director del Instituto de Salud Carlos III.
Miguel Palomino Segura, Georgiana Crainiciuc, Jon Sicilia y Andrés Hidalgo
Research
5 Jan 2022

Scientists at the CNIC have developed a simple model for studying the behavior of immune cells in live animals and have identified a harmful cell behavior pattern associated with cardiovascular disease


Álvaro Macías, Jesús Vázquez, Pilar Gonzalo, Carla Espinós, Beatriz Dorado, Emilio Camafeita, Vicente Andrés, María J Andrés, Cristina González, Amanda Sánchez, Víctor Fanjul.
Research
26 Oct 2021

Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal


About the CNIC
6 Aug 2021

CNIC and the Mario Negri Institute in Milan (Italy) coordinate REBOOT, a project that aims to study whether treatment with beta-blockers is beneficial for patients who have suffered a myocardial infarction

Dra. Sabio
About the CNIC
17 Jun 2021

The jury acknowledged this CNIC researcher's contribution to understanding why obesity causes cardiometabolic diseases.

About the CNIC
8 Jun 2021

Dr Enríquez and Dr del Pozo Muñoz join their colleagues Dr Miguel Torres, Dr Pura Muñoz and Dr Francisco Sánchez Madrid,  bringing to five the number of CNIC members in EMBO

Jacky Goetz
About the CNIC
28 Apr 2021

Dr. Jacky Goetz works on intravital imaging and biomechanical forces during the progression of tumors.

De izda. a dcha.: Verónica Casquero, Sofía Sánchez, Irene García, Macarena Fernández, Wen Luo, Severin Muhleder, Lourdes García, Rui Benedito
Research
9 Dec 2020

Científicos del CNIC han descubierto un mecanismo celular y molecular que puede ayudar a promover la arterialización y perfusión en los tejidos que han sufrido una reducción del riego sanguíneo.

Alfonso Mora, María Elena Rodríguez Andrés, Guadalupe Sabio, Alejandro Rosell, Cintia Folgueira and Luis Leiva-Vega.
Research
30 Jun 2020

CNIC scientists have designed an animal model to study the development of liver cancer caused by bile acids